NYSE

IDEX Corporation (IEX)

♄ 637 Thanks from members

IDEX Corporation (IEX) exhibits a robust financial performance characterized by record Q2 2026 sales and raised full-year guidance, balanced by cautious analyst warnings regarding its premium P/E valuation relative to peers.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →